Research workbench
Crystal structure of escherichia COLI phnd in complex with 2- aminoethyl phosphonate
Analyse Crystal structure of escherichia COLI phnd in complex with 2- aminoethyl… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 3P7I
- Type
- protein
- Length
- 300 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Phnd, subunit of alkylphosphonate ABC transporter
- UniProt
- Q1R3F7
- Ligands
- P7I
- Pockets
- 2 · best druggability 0.57
Structure
x-ray diffraction · 1 distinct chain · 52% helix, 20% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Phnd, subunit of alkylphosphonate ABC transporter | protein | 300 | 52% helix, 20% strand | Q1R3F7 |
Ligands and binding sites
- P7I · (2-aminoethyl)phosphonic acid · ligand · chains A
- GOL · Glycerol · additive · 3 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 170 | 0.57 | 0.81 | 35 | empty |
| 2 | 60 | 0.29 | 0.74 | 15 | empty |
Compared structures
- 3P7I · Crystal structure of Escherichia coli PhnD in complex with 2-aminoethyl phosphonate · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q1R3F7
- Elsewhere: RCSB PDB 3P7I · PDBe 3P7I · UniProt Q1R3F7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.